Celecoxib and rofecoxib ADRs compared with meloxicam

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1409, 2003-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Events Associated with Long-Term Use of Celecoxib, Rofecoxib and Meloxicam in Taiwan: An Observational Study

By Huang Weng-Foung

Drug Safety, Vol. 29, Iss. 3, 2006-01 ,pp. : 261-272

Adis International

Access to resources Recommend Favorite

Rofecoxib [Vioxx] appears to increase the risk of myocardial infarction (MI) and sudden cardiac death (SCD) compared with celecoxib

Reactions Weekly, Vol. 1, Iss. 1020, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Rofecoxib [Vioxx] appears to increase the risk of myocardial infarction (MI) and sudden cardiac death (SCD) compared with celecoxib

Inpharma, Vol. 1, Iss. 1456, 2004-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Fewer GI complications with rofecoxib and celecoxib

Inpharma, Vol. 1, Iss. 1240, 2000-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Celecoxib and rofecoxib: risk of GI bleeding

Inpharma, Vol. 1, Iss. 1318, 2001-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite